Merck & Co. has reached an agreement to pay $50 million to settle hundreds of Gardasil lawsuits, which raise allegations that the controversial HPV vaccine’s side effects left young adults with serious neurological and other adverse health problems.
The Gardasil settlement was reported by Bloomberg News on June 4, indicating that the deal was confirmed in an emailed statement from Merck officials. Following years of litigation, Merck claims that the payouts should resolve all lawsuits over the HPV vaccine, except for one remaining case.
First introduced in 2006, Gardasil is a widely used vaccine administered to young girls and boys for the prevention of human papillomavirus, or HPV, infections, which can cause cervical cancer and other forms of cancer. HPV is sexually transmitted, and the vaccine has been promoted as an important tool for preventing HPV-related cancers later in life.
Gardasil Settlement Will Result in $50M Payout by HPV Vaccine Manufacturer
American Buddhist Net 